Terns Pharmaceuticals (TERN) Leases (2022 - 2023)
Historic Leases for Terns Pharmaceuticals (TERN) over the last 2 years, with Q3 2023 value amounting to $671000.0.
- Terns Pharmaceuticals' Leases fell 4380.23% to $671000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $671000.0, marking a year-over-year decrease of 4380.23%. This contributed to the annual value of $1.0 million for FY2022, which is N/A changed from last year.
- Latest data reveals that Terns Pharmaceuticals reported Leases of $671000.0 as of Q3 2023, which was down 4380.23% from $756000.0 recorded in Q2 2023.
- In the past 5 years, Terns Pharmaceuticals' Leases ranged from a high of $1.4 million in Q1 2022 and a low of $671000.0 during Q3 2023